share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股SEC公告 ·  07/09 16:17
Moomoo AI 已提取核心訊息
On July 5, 2024, SeaStar Medical Holding Corporation, a Delaware-based company, was named as a defendant in a class action lawsuit filed by Forrest A K Wells, a purported shareholder. The lawsuit, filed in the United States District Court for the State of Colorado, alleges that SeaStar Medical and its management made material misstatements and omissions about the company's business operations and FDA approval processes for its product candidates. These allegations follow a restatement of the company's consolidated financial statements, which was disclosed in a Form 8-K filing on March 27, 2024. The lawsuit asserts claims under Section 10(b) and Section 20(a) of the Exchange Act, seeking compensatory and other damages. SeaStar Medical has announced its intention to vigorously defend against the claims. The company's common stock and warrants are listed on The Nasdaq Stock Market under the symbols ICU and ICUCW, respectively.
On July 5, 2024, SeaStar Medical Holding Corporation, a Delaware-based company, was named as a defendant in a class action lawsuit filed by Forrest A K Wells, a purported shareholder. The lawsuit, filed in the United States District Court for the State of Colorado, alleges that SeaStar Medical and its management made material misstatements and omissions about the company's business operations and FDA approval processes for its product candidates. These allegations follow a restatement of the company's consolidated financial statements, which was disclosed in a Form 8-K filing on March 27, 2024. The lawsuit asserts claims under Section 10(b) and Section 20(a) of the Exchange Act, seeking compensatory and other damages. SeaStar Medical has announced its intention to vigorously defend against the claims. The company's common stock and warrants are listed on The Nasdaq Stock Market under the symbols ICU and ICUCW, respectively.
2024年7月5日，總部位於特拉華州的SeaStar Medical Holding Corporation被聲稱的股東Forrest A k Wells在科羅拉多州聯邦地區法院提起集體訴訟的被告。此訴訟指控SeaStar Medical及其管理層在公司業務運營和FDA批准其產品候選藥方面做出了實質性的不實陳述和遺漏。這些指控在公司基本報表被重述的後披露於2024年3月27日提交的8-k表格中。訴訟聲稱追究《證券交易法》第10（b）條和第20（a）條下的賠償和其他損害賠償。SeaStar Medical已宣佈其有意對這些指控進行積極辯護。公司的普通股和warrants分別在納斯達克股票交易所上市，股票代碼分別爲ICU和ICUCW。
2024年7月5日，總部位於特拉華州的SeaStar Medical Holding Corporation被聲稱的股東Forrest A k Wells在科羅拉多州聯邦地區法院提起集體訴訟的被告。此訴訟指控SeaStar Medical及其管理層在公司業務運營和FDA批准其產品候選藥方面做出了實質性的不實陳述和遺漏。這些指控在公司基本報表被重述的後披露於2024年3月27日提交的8-k表格中。訴訟聲稱追究《證券交易法》第10（b）條和第20（a）條下的賠償和其他損害賠償。SeaStar Medical已宣佈其有意對這些指控進行積極辯護。公司的普通股和warrants分別在納斯達克股票交易所上市，股票代碼分別爲ICU和ICUCW。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息